The economic debacle started in the United States due to the housing crisis has affected sharply all the world. All economic sectors were hit, feeling intensely the consequences of the problem. However, following a historical trend, the pharmaceutical industry, once it is based on commodities, experienced a lesser economic impact and kept business with a growth prospect.

Even with the performance of the so dependent national pharmaceutical industry on currency fluctuations, especially because Brazilian imports are for about U.S. $ 2 billion annually with commodities, the year 2008 ended with a increase of 52% on medicines and raw materials’s exports.

Confirming the initial estimation, Brazilian exports of medicines and raw materials, according to dates from the Foreign Trade Department of Ministry of Development, Industry and Foreign Trade (MDIC), surpassed $ 1 billion in 2008.

Several were the factors that promoted this growth, but we should highlight the fact that several international companies have chosen Brazil for its merits as a platform for raw material exports, particularly of medicine.

For the president of the Brazilian Pharmachemicals Association (Abiquif), Onesimus Azara Pereira, another positive factor for the increase of these exports were the exposure of the Brazilian pharmaceutical chemistry industry in the international market, selling outside the country the image of quality and reliability of pharmaceutical raw materials produced in Brazil.

Lanza Pharma, for example, which belongs to a group of six international companies in the pharmaceutical sector, with headquarters in Brazil and offices in China, India and Germany, in 2008 had a record of positive balance of 30% over the previous year. According to the company’s president Vanderlanzs Dantas, Lanza Pharma faced a reduction in business, however they kept the goal to maintain the company operating normally, the jobs and the maintenance of business.

The company is responsible for a significant portion on the Brazilian economy, contributing with high volume of generic medicines generated in recent years.

The pharmaceutical industry, therefore, kept on going during the crisis with good answers and solutions, making use of the reliability and quality of Brazilian raw materials by seriousness and capacitance of companies such as Lanza Pharma.